FINWIRES · TerminalLIVE
FINWIRES

CF Industries to Benefit From Strong Nitrogen Prices, Cash Flow Amid US-Iran Risks, RBC Says

By

CF Industries (CF) could benefit from firm nitrogen prices, tight global supply, strong cash flow and ongoing cost improvements, though the US-Iran conflict could keep near-term results volatile, RBC Capital Markets said in a note Monday.

The investment firm expects nitrogen prices to stay high in the near term as Middle East supply remains limited, with further upside possible if tensions rise or demand improves in H2. RBC said US NOLA urea prices are expected at $489 per ton in 2026 and $413 per ton in 2027, compared with $399 per ton in 2025.

CF's efforts to improve margins, including higher-value low-carbon ammonia sales and changes at its Courtright and Yazoo City facilities, could support earnings over time, according to the note.

The investment firm expects strong cash flow in 2026 to give the company room for larger stock buybacks, while cash generation should remain solid from 2027 through 2029 as spending increases on the Blue Point project, which remains on track to begin construction in August, with required permits received in July and most long-lead items ordered, while modular construction is limiting labor-cost risks.

RBC kept its sector perform rating and $115 price target, saying it remains constructive on CF's longer-term outlook but expects near-term risks from the US-Iran conflict and potential downward earnings estimate revisions.

Price: $118.15, Change: $+3.80, Percent Change: +3.32%

Related Articles

Wire

GRAIL's Galleri Blood Test to Be Evaluated by US FDA Advisory Panel

GRAIL (GRAL) said Friday that an advisory panel of the US Food and Drug Administration will convene on Sept. 23 to evaluate the premarket approval application for its Galleri multi-cancer early detection blood test.The firm submitted the marketing application Jan. 29, incorporating trial results from 25,490 participants in its PATHFINDER 2 study along with over 70,000 subjects from its NHS-Galleri trial, the company said.Shares of the company were up about 8.9% in Friday trading.Price: $69.03, Change: $+5.63, Percent Change: +8.88%

$GRAL
Wire

Top Cryptocurrencies Rise; Bitcoin Holds Above $64,000

Major digital assets rose Friday with Bitcoin (BTC-USD) still holding above $64,000.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, rose 0.3% in the past 24 hours. The Nasdaq 100 added 1.3%, the S&P 500 gained 0.6%, and the Dow Jones Industrial Average increased 0.2%.Bitcoin gained 0.9% to $64,938, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume rose almost 11% to $21.65 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, rose 0.6% to $1,918.XRP (XRP-USD) fell 1.1%, BNB (BNB-USD) increased 0.5%, and Solana (SOL-USD) rose 1.5%. Dogecoin (DOGE-USD) added 1.6%, while Cardano (ADA-USD) dropped 0.8%.The total market value of the cryptocurrency industry rose 0.6% in the past 24 hours to $2.21 trillion, with trading volume rising 5.3% to $55.6 billion.Price: $64913.74, Change: $+654.06, Percent Change: +1.02%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD
Wire

Celestica Completes $3.45 Billion Equity Offering

Celestica (CLS) said Friday it completed a $3.45 billion equity offering through the sale of about 11.1 million common shares priced at $310 each.The offering comprised roughly 9.7 million common shares, with the underwriters fully exercising their option to purchase an additional 1.5 million shares.Celestica said it expects to use the net proceeds for working capital, investments in capital expenditures and other general corporate purposes.Price: $317.60, Change: $+3.07, Percent Change: +0.98%

$CLS